Proven to significantly reduce excess abdominal fat.
EGRIFTA SV® is not indicated for weight loss management.See the Results
It stimulates the body's own pulsatile release of growth hormone.Learn about the mechanism of action
*An approved strength of tesamorelin for injection with the same efficacy and safety of tesamorelin 1 mg/vial. The 2 mg/vial is more concentrated than the 1 mg/vial, and the recommended daily dose is 1.4 mg.